Literature DB >> 22196935

Recently postmenopausal women have the same prevalence of subclinical carotid atherosclerosis as age and traditional risk factor matched men.

Kimon S Stamatelopoulos1, Eleni Armeni, Georgios Georgiopoulos, Maria Kazani, Katerina Kyrkou, Konstantinos Stellos, Athanasios Koliviras, Andreas Alexandrou, Maria Creatsa, Christos Papamichael, Irene Lambrinoudaki.   

Abstract

OBJECTIVE: To compare the prevalence of subclinical atherosclerosis between postmenopausal women and men of similar age early after the onset of menopause.
METHODS: In the first part of this cross-sectional study 186 non-diabetic young postmenopausal women (n = 101, menopausal age ≤ 10 years) and men (n = 85) aged 40-60 years without overt CVD were consecutively recruited from the outpatients clinics of an academic hospital. Subclinical carotid atherosclerosis was assessed by high-resolution ultrasonography. The presence of carotid atherosclerosis was defined as either increased carotid intima-media thickness (IMT>0.9 mm) and/or the presence of plaques. In the second part, 1:1 matching for age and traditional risk factors (hyperlipidemia, smoking, hypertension and BMI) was performed between men and women of this cohort resulting in a matched sub-sample of 76 subjects.
RESULTS: By multivariate analysis, gender was not an independent determinant of any measure of carotid atherosclerosis. In the matched sub-sample, carotid IMT and the number of segments with atherosclerosis did not significantly differ between women and men (0.734 ± 0.119 mm and 1.47 ± 1.6 versus 0.717 ± 0.138 mm and 1.47 ± 1.5, p = 0.575 and p = 0.999, respectively). Also, the prevalence of increased IMT (60.5% in both genders), carotid plaques and subclinical atherosclerosis (31.6% and 63.2% versus 28.9% and 65.8%, p = 0.803 and p = 0.811, respectively) was similar between men and women.
CONCLUSIONS: The prevalence and severity of carotid atherosclerosis was similar between men and young postmenopausal women matched for traditional risk factors. Whether these women may be better risk stratified irrespective of gender should be further assessed in prospective studies.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22196935     DOI: 10.1016/j.atherosclerosis.2011.12.006

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

1.  High prevalence of subclinical atherosclerosis in Brazilian postmenopausal women with low and intermediate risk by Framingham score.

Authors:  Ana Claudia Gomes Pereira Petisco; Jorge Eduardo Assef; Carlos Alberto de Jesus; Mohamed Hassan Saleh; Jose Eduardo Martins Barbosa; David Costa de Souza Le Bihan; Ibraim Masciarelli França Pinto; Simone Rolim Fernandes Fontes Pedra; Rodrigo Bellio de Mattos Barretto; Amanda Guerra de Moraes Rego Sousa
Journal:  Int J Cardiovasc Imaging       Date:  2016-10-20       Impact factor: 2.357

2.  Gender differences in the risk factors associated with atherosclerosis by carotid intima-media thickness, plaque score, and pulse wave velocity.

Authors:  Satoko Ojima; Takuro Kubozono; Shin Kawasoe; Takeko Kawabata; Hironori Miyahara; Koichi Tokushige; Mitsuru Ohishi
Journal:  Heart Vessels       Date:  2021-01-25       Impact factor: 2.037

3.  Association between global leukocyte DNA methylation and cardiovascular risk in postmenopausal women.

Authors:  Ramon Bossardi Ramos; Vitor Fabris; Sheila Bunecker Lecke; Maria Augusta Maturana; Poli Mara Spritzer
Journal:  BMC Med Genet       Date:  2016-10-10       Impact factor: 2.103

Review 4.  Estrogen Deprivation and Myocardial Infarction: Role of Aerobic Exercise Training, Inflammation and Metabolomics.

Authors:  Olívia M Ruberti; Bruno Rodrigues
Journal:  Curr Cardiol Rev       Date:  2020

Review 5.  Estrogen Receptor and Vascular Aging.

Authors:  Morgane Davezac; Melissa Buscato; Rana Zahreddine; Patrick Lacolley; Daniel Henrion; Francoise Lenfant; Jean-Francois Arnal; Coralie Fontaine
Journal:  Front Aging       Date:  2021-09-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.